Evidence map›Paper›PMID 30293990›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2019

Molecular autopsy by trio exome sequencing (ES) and postmortem examination in fetuses and neonates with prenatally identified structural anomalies.

Elizabeth Quinlan-Jones, Jenny Lord, Denise Williams, Sue Hamilton, Tamas Marton, Ruth Y Eberhardt, Gabriele Rinck, Elena Prigmore, Rebecca Keelagher, Dominic J McMullan and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2026
    Article
  3. [Establish Standardized Pathological and Genetic Examinations to Reduce the Incidence of Stillbirth].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Review
  4. Genetics and Stillbirth.Clinics in perinatology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Implications of Genomic Newborn Screening for Infant Mortality.International journal of neonatal screening · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Elizabeth Quinlan-Jones *Department of Clinical Genetics, Birmingham Women's & Children's NHS Foundation Trust, Birmingham, UK.
Jenny Lord *Wellcome Sanger Institute, Hinxton, Cambridge, UK.
Denise WilliamsDepartment of Clinical Genetics, Birmingham Women's & Children's NHS Foundation Trust, Birmingham, UK.
Sue HamiltonWest Midlands Regional Genetics Service, Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, UK.
Tamas MartonWest Midlands Regional Perinatal Pathology Service, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
Ruth Y EberhardtWellcome Sanger Institute, Hinxton, Cambridge, UK.
Gabriele RinckWellcome Sanger Institute, Hinxton, Cambridge, UK.
Elena PrigmoreWellcome Sanger Institute, Hinxton, Cambridge, UK.
Rebecca KeelagherWest Midlands Regional Genetics Service, Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, UK.
Dominic J McMullanWest Midlands Regional Genetics Service, Birmingham Women's and Children's Hospital NHS Foundation Trust, Birmingham, UK.
Eamonn R Maher *Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
Matthew E Hurles *Wellcome Sanger Institute, Hinxton, Cambridge, UK.
Mark D Kilby *West Midlands Fetal Medicine Centre, Birmingham Women's & Children's NHS Foundation Trust, Birmingham, UK. M.D.Kilby@bham.ac.uk.
Birmingham Women’s and Children’s NHS Foundation Trust · GBWellcome Sanger Institute · GBNIHR Cambridge Biomedical Research Centre

Funding

Department of HealthWellcome Trust
6 · The paper itself

Abstract

purposeTo determine the diagnostic yield of combined exome sequencing (ES) and autopsy in fetuses/neonates with prenatally identified structural anomalies resulting in termination of pregnancy, intrauterine, neonatal, or early infant death.

methodsES was undertaken in 27 proband/parent trios following full autopsy. Candidate pathogenic variants were classified by a multidisciplinary clinical review panel using American College of Medical Genetics and Genomics (ACMG) guidelines.

resultsA genetic diagnosis was established in ten cases (37%). Pathogenic/likely pathogenic variants were identified in nine different genes including four de novo autosomal dominant, three homozygous autosomal recessive, two compound heterozygous autosomal recessive, and one X-linked. KMT2D variants (associated with Kabuki syndrome postnatally) occurred in two cases. Pathogenic variants were identified in 5/13 (38%) cases with multisystem anomalies, in 2/4 (50%) cases with fetal akinesia deformation sequence, and in 1/4 (25%) cases each with cardiac and brain anomalies and hydrops fetalis. No pathogenic variants were detected in fetuses with genitourinary (1), skeletal (1), or abdominal (1) abnormalities.

conclusionThis cohort demonstrates the clinical utility of molecular autopsy with ES to identify an underlying genetic cause in structurally abnormal fetuses/neonates. These molecular findings provided parents with an explanation of the developmental abnormality, delineated the recurrence risks, and assisted the management of subsequent pregnancies.

Indexed as

AutopsyCohort StudiesCongenital AbnormalitiesExomeExome SequencingFemaleFetal DiseasesFetusHumansInfant, NewbornMalePregnancyPrenatal Diagnosisautopsyexome sequencingfetusesgenetic diagnosisneonates

Identifiers

PMID30293990
PMCPMC6752266
OpenAlexW2895509965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.